CD40L-adjuvanted DNA vaccine carrying EBV-LMP2 antigen enhances anti-tumor effect in NPC transplantation tumor animal

CD40L, a costimulatory molecule for dendritic cells (DCs) and B cells, can serve as an adjuvant for enhancing the specific immune response induced by DNA vaccine carrying tumor-associated antigens. In this study, we investigated the potential of CD40L as an adjuvant to enhance the anti-tumor effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Lei, Li, Jianhui, Liu, Meiqing, Hu, Xiaoming, Zhou, Ya, Yang, Shiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2018
Materias:
Experimental Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102622/
https://www.ncbi.nlm.nih.gov/pubmed/30135622
http://dx.doi.org/10.5114/ceji.2018.77379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102622/
https://www.ncbi.nlm.nih.gov/pubmed/30135622
http://dx.doi.org/10.5114/ceji.2018.77379

Ejemplares similares